A Transcellular Assay to Assess the P-gp Inhibition in Early Stage of Drug Development

E-ISSN： 1874-0758|6|4|285-291

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.6, Iss.4, 2012-12, pp. : 285-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer

By Patil Anand

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 36, Iss. 3, 2011-09 ,pp. : 115-119

Springer Publishing Company

Access to resources Recommend Favorite

Digoxin toxicity with SSRIs not augmented by P-gp inhibition

Reactions Weekly, Vol. 1, Iss. 1039, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

A Simplified Protocol Employing Elacridar in Rodents: A Screening Model in Drug Discovery to Assess P-gp Mediated Efflux at the Blood Brain Barrier

Drug Metabolism Letters, Vol. 6, Iss. 2, 2012-01 ,pp. : 134-144

Bentham Science Publishers

Access to resources Recommend Favorite

P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update

Current Drug Metabolism, Vol. 17, Iss. 8, 2016-08 ,pp. : 806-826

Bentham Science Publishers

Access to resources Recommend Favorite

In Silico, In Vitro and In Situ Models to Assess Interplay Between CYP3A and P-gp

Current Drug Metabolism, Vol. 12, Iss. 8, 2011-10 ,pp. : 750-773

Bentham Science Publishers

Access to resources Recommend Favorite